The Bloodline with LLS

Tania Jain, MBBS What does a myelofibrosis (MF) diagnosis really mean, and how does it fit within a group of conditions called myeloproliferative neoplasms, or MPNs? In this episode, we're joined by Dr. Tania Jain of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, who helps break it all down in a clear and approachable way. She discusses how myelofibrosis affects the bone marrow, common symptoms to watch for, and how treatment options are tailored to each person. From managing day-to-day challenges to understanding when more advanced treatments may be considered, this conversation focuses on what matters most to patients and families. As Dr. Jain shares, “every patient writes their own story,” noting that advancing research offers genuine hope. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Myelofibrosis (MF) DIPSS/DIPSS plus myelofibrosis scoring Myelofibrosis: Charting the Course for Care Allogeneic stem cell transplantation Acute myeloid leukemia (AML) Clinical Trial Support Center Online Chat Additional Blood Cancer United Support Resources: Information Specialists Financial support Free Nutrition Consultations Free telephone/web patient programs Free booklets Patient Community Support groups Caregiver support Caregiver Workbook Young Adult Resources Survivorship Workbook Advocacy and Public Policy Mental Health Resources Episode supported by Takeda Oncology.The post Myelofibrosis (MF): More Options, More Hope first appeared on The Bloodline with Blood Cancer United Podcast.

Some people with chronic lymphocytic leukemia (CLL) may feel well day to day, but that doesn't mean life stays the same. In this episode, we hear from Annette Holloway, a clinical psychologist living with CLL, as she shares how her diagnosis, treatment decisions, and side effects have shaped her daily life. Also joining us is Elise Curry, RN, OCN, a Clinical Trial Nurse Navigator at Blood Cancer United's Clinical Trial Support Center, who helps break down treatment options, side effects, and the importance of communication with your care team. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Chronic lymphocytic leukemia (CLL) Clinical Trial Support Center Minimal/measurable residual disease (MRD) Patti Robinson Kaufmann First Connection ® program Online Chat Patient Community Support groups Caregiver support Lessons in Blood Cancer Video: CLL Shared Decision Making in Chronic Leukemias interactive program CLL Society Patient Power Additional Blood Cancer United Support Resources: Information Specialists Financial support Free Nutrition Consultations Free telephone/web patient programs Free booklets Caregiver Workbook Young Adult Resources Survivorship Workbook Advocacy and Public Policy Mental Health Resources Episode supported by AbbVie Inc.; BeOne Medicines; and Genentech, A Member of the Roche Group.The post Chronic Lymphocytic Leukemia (CLL): Managing Treatment and Finding Balance first appeared on The Bloodline with Blood Cancer United Podcast.

Rebecca Olin, MD, MSCE Acute myeloid leukemia (AML) is a complex diagnosis, and it can be difficult to know what to expect in those early conversations after diagnosis. In this episode, we speak with Dr. Rebecca Olin from the University of California, San Francisco (UCSF), who helps explain what AML is and how care is approached today. Dr. Olin walks us through how doctors evaluate AML, what factors influence treatment decisions, and how therapies – including targeted treatments, stem cell transplant, and clinical trials – are helping improve outcomes and quality of life. We also discuss the importance of supportive care and ongoing research, offering listeners a clearer picture of how AML is treated now and where progress continues to be made. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Acute myeloid leukemia Allogeneic stem cell transplantation Clinical Trial Support Center Beat AML® Master Clinical Trial Beat AML® press release – January 2026 Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Support groups Caregiver support Caregiver Workbook Young Adult Resources Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Astellas Pharma US Inc.; Daiichi Sankyo Inc.; Debiopharm; Genentech, A Member of the Roche Group; and Kura Oncology, Inc. The post Acute Myeloid Leukemia (AML): New Approaches For A Complex Diagnosis first appeared on The Bloodline with Blood Cancer United Podcast.

Chris Pagliarulo A cancer diagnosis in your 20s or 30s can raise questions most people never expect to face so early in life. In this episode, we speak with Chris Pagliarulo, who was diagnosed with Hodgkin lymphoma at the age of 29, about the medical, emotional, and practical realities of cancer during early adulthood. We explore issues that are especially relevant for adolescent and young adult (AYA) patients, including delayed diagnosis, fertility preservation, treatment side effects, career disruption, relationships, and finding connection with others who understand. While this conversation highlights experiences unique to AYAs, patients and caregivers of all ages may hear pieces of their own experience reflected in what Chris shares. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Young Adult Resources Hodgkin lymphoma Fertility and family planning resources Patti Robinson Kauffman First Connection® Light The Night Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Clinical Trial Support Center Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources The post A Young Adult Story: Cancer, Connection, and Life After Treatment first appeared on The Bloodline with Blood Cancer United Podcast.

Marlise Luskin, MD With so many new advances in acute lymphoblastic leukemia (ALL), understanding today's treatment landscape can give patients a clearer, more hopeful outlook. In this episode, we speak with Marlise Luskin, MD of the Dana-Farber Cancer Institute, about what adults should know when facing a diagnosis of acute lymphoblastic leukemia. Dr. Luskin helps listeners understand how ALL develops, how subtypes are identified, and why genetics play an important role in guiding treatment. She discusses current therapies including chemotherapy, targeted agents and immunotherapies including CAR T-cell therapy, as well as how care teams monitor progress and manage side effects. While ALL is a complex disease, patients and caregivers will hear clear explanations, practical information, and meaningful reasons to feel hopeful about the advances shaping ALL care today. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Acute lymphoblastic leukemia (ALL) Minimal/measurable residual disease (MRD) fact sheet Allogeneic stem cell transplantation Clinical Trial Support Center ALL Children and Teens booklet Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Support groups Caregiver support Caregiver Workbook Young Adult Resources Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Syndax Pharmaceuticals Inc. The post Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.

Andrew Yee, MD Multiple myeloma can feel unfamiliar and overwhelming at first, but today's advances tell a much brighter story. In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it's diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Multiple myeloma Amyloidosis Autologous stem cell transplantation CAR T-cell therapy Immunotherapy fact sheet Clinical Trial Support Center Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson. The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first appeared on The Bloodline with Blood Cancer United Podcast.

CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapy Clinical Trial Support Center CAR T-Cell Therapy: A Path of Hope and Healing Video Series Bloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell Therapy Hematology Horizons vlog: CAR T-Cell Therapy and the Patient Experience CAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; Novartis Pharmaceuticals Corporation. The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first appeared on The Bloodline with Blood Cancer United Podcast.

Stefan Barta, MD, MS Cutaneous T‑cell lymphoma (CTCL) is a rare condition that often raises important questions for patients and families. In this episode, we sit down with Dr. Stefan Barta, of the University of Pennsylvania, to bring clarity to what CTCL is, how it's diagnosed, and what patients can expect from staging and treatment. Dr. Barta breaks down the differences between CTCL subtypes, explains why diagnosing someone can take time, and shares the most up-to-date therapies, including skin directed treatments, immunotherapies, and emerging clinical trial options. Most importantly, he offers reassurance for those newly diagnosed: “The future is absolutely bright… there is a lot of hope for our patients with CTCL.” DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Cutaneous T-cell lymphoma Cutaneous Lymphoma Foundation Clinical Trial Support Center Additional Blood Cancer United Support Resources: Free Nutrition Consultations Information Specialists Financial support Online Chat Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Kyowa Kirin, Inc. and Cutaneous Lymphoma Foundation.The post Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward first appeared on The Bloodline with Blood Cancer United Podcast.

Mikkael A. Sekeres, MD, MS Curious about what's new in the world of myelodysplastic syndromes (MDS)? We're bringing you the latest insights straight from one of the field's leading experts. In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it's treated today, and what researchers are learning about managing side effects. Dr. Sekeres also walks us through the most notable MDS updates presented at ASH, highlighting promising therapies and clinical trial data that may help shape future care. Whether you're newly learning about MDS or following ongoing research, this episode offers an accessible look at where things stand and what's on the horizon. *This is not an official program of the ASH annual meeting DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Myelodysplastic syndromes International Prognostic Scoring System for MDS American Society of Hematology Highlights from ASH vlog Blood cancer research 2026: Meeting patients where they want to be | blog post Additional Blood Cancer United Support Resources: Free Nutrition Consultations Information Specialists Financial support Clinical Trial Support Center Online Chat Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Episode supported by Geron Corporation and Taiho Oncology, Inc.The post The Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in Research first appeared on The Bloodline with Blood Cancer United Podcast.

Ann Grace MacMullan, C-IAYT In this episode, we sit down with Ann Grace MacMullan, Director of Integrative Wellness at the International Waldenstrӧm's Macroglobulinemia Foundation (IWMF), to explore how wellness can become a powerful part of life after a cancer diagnosis. Ann Grace shares practical, calming techniques, including breathing exercises, “Bee's Breath”, and guided meditation, that you can do anywhere to reduce stress and feel more grounded. We'll also dive into what integrative wellness really means, why it matters for blood cancer patients, and how concepts like the “self-care sandwich” can help you start and end your day with intention. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Integrative oncology Palliative care How Do I Use Breathing To Manage Anxiety? IWMF wellness videos Integrative Oncology podcast episode International Waldenstrom's Macroglobulinemia Foundation (IWMF) Additional Blood Cancer United Support Resources: Free Nutrition Consultations Information Specialists Financial support Clinical Trial Support Center Online Chat Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources The post Hope Meets Healing: Simple Practices for Stress Relief first appeared on The Bloodline with Blood Cancer United Podcast.

Jean Koff, MD, MSc Non-Hodgkin lymphoma (NHL) can sound overwhelming, but what does it really mean for patients and families? In this episode, we speak to Dr. Jean Koff of Winship Cancer Institute of Emory University, who breaks down the big picture of NHL: what it is, how it's an umbrella term for multiple subtypes, and what today's treatments and tomorrow's innovations could mean for you. From understanding subtypes and staging to exploring options like watchful waiting, chemotherapy, and cutting-edge immunotherapies, we cover what matters most: knowledge, clarity, and hope. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Non-Hodgkin lymphoma The Lymphoma Guide Lugano staging system Immunotherapy fact sheet CAR T-cell therapy Allogeneic stem cell transplantation Clinical Trial Support Center Online NHL Chat Additional Blood Cancer United Support Resources: Free Nutrition Consultations Information Specialists Financial support Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Patient Community Mental Health Resources Supported by AbbVie Inc. and Genentech, A Member of the Roche Group.The post The Big Picture on Non-Hodgkin Lymphoma: Treatments, Trends, and Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.

Michell Fullmer, RDN, LDN, CSP, CNSC Nutrition plays a powerful role in supporting children through cancer treatment, but it's not always easy for caregivers to know what's best, especially when there are taste changes, appetite shifts, and treatment side effects. In this episode, we sit down with Michell Fullmer, a registered dietitian at Nemours Children's Hospital, to share practical insights that simplify nutrition during cancer care, reduce mealtime stress, and empower caregivers to make choices that help their child feel better every day. Join us for myth-busting, actionable tips, and reassurance from an expert who has guided countless families through this important part of care. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Free Nutrition Consultations Nemours Children's Health Blood Cancer United Dare To Dream Project Navigating Cancer for Children and Teens HealthyWeight.gov Additional Blood Cancer United Support Resources: Information Specialists Free telephone/web patient programs Clinical Trial Support Center Advocacy and Public Policy Free booklets Financial support Young Adult Resources Support groups Survivorship Workbook Community Caregiver support Caregiver Workbook Mental Health Resources Supported by Nemours Children's Health. The post Nutrition Made Simple: Helping Kids Thrive During Cancer Treatment first appeared on The Bloodline with Blood Cancer United Podcast.

In this episode, we are joined by Dr. Abdulraheem Yacoub of The University of Kansas Cancer Center to discuss myeloproliferative […] The post After Diagnosis: Finding Hope with Myeloproliferative Neoplasms first appeared on The Bloodline with Blood Cancer United Podcast.

When cancer enters a family, it changes everything – routines, roles, and relationships. In this episode, we talk with Lindsey […] The post Supporting the Supporter: Real Talk for Caregivers first appeared on The Bloodline with Blood Cancer United Podcast.

MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers.  In this episode, we talk […] The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.

Choosing the right health insurance plan can make all the difference in protecting your health and finances. In this episode, […] The post Health Coverage for 2026 and Protecting Yourself from Medical Debt first appeared on The Bloodline with Blood Cancer United Podcast.

In this episode of The Bloodline with Blood Cancer United, Elissa and guest co-host, Kristen Parker, speak with Dr. Anand […] The post Acute Promyelocytic Leukemia (APL): Advances, Hope, and Healing first appeared on The Bloodline with Blood Cancer United Podcast.

In this special episode of The Bloodline, we introduce our new name and what it means for blood cancer patients, […] The post We are Blood Cancer United: a new name, an unstoppable community first appeared on The Bloodline with Blood Cancer United Podcast.

En este episodio damos la bienvenida al Dr. Eduardo Bruera, distinguido oncólogo médico y jefe del Departamento de Medicina Paliativa, […] The post Cuidados paliativos: Más de lo que piensas first appeared on The Bloodline.

In this episode, we speak with Dianne Callahan, four-time cancer survivor, best-selling author, speaker, and patient advocate. Dianne shares her […] The post Joy, Hope, and Healing Beyond a Cancer Diagnosis first appeared on The Bloodline.

What happens when a sibling match becomes the key to survival? In this heartfelt episode, we speak with Peter and… The post Siblings, Stem Cells, and Second Chances first appeared on The Bloodline with LLS.

Firefighters risk their lives every day—but what happens when some dangers aren't in the flames, but in the long-term health… The post Sound the Alarm: Firefighter Health, Cancer Risk, and Moving Forward first appeared on The Bloodline with LLS.

In this episode, we're joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic… The post Partnering in Care: Chronic Lymphocytic Leukemia (CLL) first appeared on The Bloodline with LLS.

The cancer experience isn't just physical—it's deeply emotional. Join us for this special episode recorded onsite while filming our SHARE… The post LIVE! At SHARE: Emotional Wellness in Survivorship first appeared on The Bloodline with LLS.

In this episode, we speak with Mary Wells, who was diagnosed with primary myelofibrosis in 2018, a rare blood cancer… The post Choosing the Path Forward: Shared Decisions in Myelofibrosis Care first appeared on The Bloodline with LLS.

Primary Central Nervous System Lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the brain, spinal cord, or… The post Breaking Down Primary CNS Lymphoma: From Rare Diagnosis to Growing Progress first appeared on The Bloodline with LLS.

En este episodio, conocemos a Sara Grisales Jaramillo, trabajadora social, gerente de Insight y del Centro de Llamadas de CancerCare.… The post Atención Médica: Su Derecho de Abogar first appeared on The Bloodline with LLS.

Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education… The post CAR T-cell Therapy: Your Questions Answered first appeared on The Bloodline with LLS.

Acute myeloid leukemia (AML) is one of the most aggressive blood cancers—but science is making real progress. In this episode,… The post Understanding AML: The Challenges, The Progress, The Hope first appeared on The Bloodline with LLS.

Join us as we speak with Ashlee and Michael Cramer, the mother-son duo behind the Michael and Mom Talk Cancer… The post Unbreakable: A Mother & Son's Fight Against Cancer first appeared on The Bloodline with LLS.

When it comes to cancer and nutrition, there's a lot of misinformation out there. Can sugar fuel cancer? Should you… The post Cancer Nutrition: Myth Busters Edition first appeared on The Bloodline with LLS.

In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss… The post Hope in Myeloma: The Road to Long-Term Survival first appeared on The Bloodline with LLS.

A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options.  In this episode,… The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with LLS.

In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to… The post Impact of Disparity: Navigating Treatment Equality in Cancer Care first appeared on The Bloodline with LLS.

A stem cell transplant for blood cancer is just the beginning – what may come next for the patient can… The post Beyond the Transplant: Navigating Graft-vs-Host Disease (GVHD) first appeared on The Bloodline with LLS.

Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr.… The post There's Always Hope: Myelodysplastic Syndromes (MDS) first appeared on The Bloodline with LLS.

En este episodio conocemos al Dr. Mateo Mejia Saldarriaga de Weill Cornell Medicine, hospital NewYork-Presbyterian. Únase para aprender cómo los… The post Nuevos Avances Para Mieloma Múltiple first appeared on The Bloodline with LLS.

Join us as we speak to Mousa Ghannam, who was diagnosed with chronic myeloid leukemia (CML) at the age of… The post Not Cashing In My Chips: Living with Cancer first appeared on The Bloodline with LLS.

Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin… The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with LLS.

Join us for a powerful message of hope and perseverance after a cancer diagnosis. In this episode, Rashad Hayes shares… The post Don't Burn Your CAKE: Embracing Life's Challenges first appeared on The Bloodline with LLS.

Navigating the maze of cancer care can be overwhelming. Join us as Sara Grisales Jaramillo, LMSW, of CancerCare® discusses the… The post Overcoming Barriers: Navigating Cancer Care first appeared on The Bloodline with LLS.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. A… The post LIVE! At CancerCon: Ghosts, Growth and Guidance first appeared on The Bloodline with LLS.

There are new Medicare changes starting in January 2025 that will benefit cancer patients.   LLS Vice President of Federal… The post Medicare Updates: What You Need to Know for 2025 first appeared on The Bloodline with LLS.

There are new Medicare changes starting in January 2025 that will benefit cancer patients.   LLS Vice President of Federal… The post Medicare Updates: What You Need to Know for 2025 first appeared on The Bloodline with LLS.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. Following… The post LIVE! At CancerCon: Transitioning to Primary Care first appeared on The Bloodline with LLS.

Please join us for this special episode live from CancerCon®, a young adult cancer conference presented by Stupid Cancer®. Following… The post LIVE! At CancerCon: Transitioning to Primary Care first appeared on The Bloodline with LLS.

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.   However, there is a… The post Hope on the Horizon: Chronic Lymphocytic Leukemia first appeared on The Bloodline with LLS.

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.   However, there is a… The post Hope on the Horizon: Chronic Lymphocytic Leukemia first appeared on The Bloodline with LLS.

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But… The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with LLS.

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But… The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with LLS.

The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell… The post Innovative Therapies: Transforming Non-Hodgkin Lymphoma Care first appeared on The Bloodline with LLS.